Pembrolizumab Versus Placebo After Complete Resection Of High-Risk Stage Ii Melanoma: Efficacy And Safety Results From The Keynote-716 Double-Blind Phase Iii Trial

ANNALS OF ONCOLOGY(2021)

引用 31|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要